XYone Therapeutics Marks Major Milestone with First Patient Dosed in XYA02 Clinical Trial #United_States #Canton #XYone_Therapeutics #XYA02 #MUC1-C
@newsen.bsky.socialExplore
@newsen.bsky.social
@nephrogenomics.bsky.socialSharkVNTyper 1.2 is out ! another step forward for screening MUC1 kidney disease.
👉 github.com/Nephrogenomi...
#Nephrology #Genomics #RareDisease #ADTKD #MUC1 #Bioinformatics #OpenSource